Acupuncture as anticancer treatment? by unknown
The mystery of Traditional Chinese 
Medicine has been attracting people 
for years. Acupuncture, ranked among 
the most common services of Com-
plementary and Alternative Medicine, 
has recently gained a  lot of interest 
in the scientific world. Contemporary 
researchers have been continuous-
ly trying to shed light on its possible 
mechanism of action in human organ-
ism. Numerous studies pertaining to 
acupuncture’s application in cancer 
symptoms or treatment-related side 
effects management have already 
been published. Moreover, since the 
modern idea of acupuncture’s im-
munomodulating effect seems to be 
promising, scientists have propound-
ed a  concept of its potential appli-
cation as part of direct anti-tumor 
therapy. In our previous study we sum-
marized possible use of acupuncture 
in management of cancer symptoms 
and treatment-related ailments, such 
as chemotherapy-induced nausea and 
vomiting, pain, xerostomia, vasomo-
tor symptoms, neutropenia, fatigue, 
anxiety, insomnia, lymphoedema after 
mastectomy and peripheral neuropa-
thy. This article reviews the studies 
concerning acupuncture as a possible 
tool in modern anticancer treatment.
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treatment, therapy.
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Introduction 
Complementary and alternative medicine (CAM) is defined by the Nation-
al Center for Complementary and Alternative Medicine as a heterogeneous 
group comprised of a wide array of medical services that are not considered 
conventional medicine [1]. The use of CAM is widespread and increasing [2], 
hence the number of studies concerning its possible application in everyday 
clinical practice is also on the rise [3]. Acupuncture, subsumed under CAM, 
is one of the world’s oldest medical procedures [4] and has gained a lot of 
interest and appreciation over the years [5]. The popularity of this method is 
continuously increasing [6]. It has been nearly two decades now since acu-
puncture was, for the first time, introduced in oncology as a possible tool in 
care of cancer patients [7]. A lot has been written about its possible applica-
tion as supportive therapy in the oncology field and that issue was discussed 
in detail in the preview article published by our group [8]. Additionally, some 
publications suggest that acupuncture can possibly be part of a direct an-
ti-tumor therapy, mainly due to its immunomodulating effect [9, 10].  This 
review, as a continuation of the previously published study, is focused on the 
literature concerning acupuncture as antitumor therapy.
Methods
The material for the article was obtained from the literature search per-
formed independently by two authors, in Medline/PubMed database (from 
1990 to July 2014), the Cochrane Library (up to July 2014) and UpToDate. Fol-
lowing key words (in various combinations and forms) were used: ‘acupunc-
ture’, ‘CAM’, ‘immunomodulating effect’, ‘NK cell’, ‘activity’, ‘modulation’, 
‘interferon gamma’, ‘complementary’, ‘anti-tumor’, ‘therapy’ ‘cancer’, ‘anti-
cancer’, ‘treatment’, ‘oncology’, ‘application’, ‘electro-acupuncture’, ‘tumor 
volume’, ‘growth inhibition’, ‘immunotherapy’, ‘tumor response enhance-
ment’. The foregoing phrases generated from several up to over 1100 results, 
depending on the source and specificity of searched issue (e.g. ‘acupunc-
ture’ AND ‘cancer’ gives 501 results in Cochrane Library and 1153 in PubMed, 
whereas ‘acupuncture’ AND ‘anticancer’ generates 3 and 21 respectively). 
The ‘RELATED CITATION’ module in PubMed database was used in order to 
find additional articles. Only publications presenting acupuncture’s direct or 
indirect anticancer effect were included. The results of studies based on an-
imal model as well as human trials were analyzed. The ClinicalTrials.gov was 
searched to find information about currently ongoing clinical trials. Both full 
articles and abstracts were taken into consideration.
Possible mechanisms of anticancer activity
‘The acupuncture immuno-enhancement hypothesis’ 
According to this theory, acupuncture enhances anticancer immunity of 
the human body by natural killer (NK) cells stimulation [11]. This hypothe-
sis seems to be interesting since NK cells play a key role in regulating an-
ticancer immune function and directly killing cancer cells [12]. NK cells use 
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two mechanisms to kill cancer cells. The first one (secre-
tory-cytotoxic mechanism) is mediated by the secreted 
cytolytic perforins and granzymes B (serine proteases), 
which damage deoxyribonucleic acid (DNA). The second 
one (non-secretory apoptotic mechanism) involves direct 
induction of apoptosis and is mediated by Tumor Necrosis 
Factor (TNF) family ligands located on NK cells membrane, 
e.g. Fas ligand (FasL). The second mechanism, which is 
more efficient and operative against all types of cancer 
cells, seems to be the major tool of NK cells activity [13–15]. 
Thanks to these efficient and highly selective killing strat-
egies, NK cells are capable of detecting and eliminating 
newly formed and blood-borne cancer cells, and prevent 
the development of both primary tumors and their metas-
tases [11].
The majority of the researches carried out so far on im-
munomodulatory effects of acupuncture have been focused 
on the stimulation of ST-36 acupoint, located on the pathway 
of the stomach meridian (Zusanli point, which is located 
5 cm below the patella and 2 cm lateral of the anterior crest of 
the tibialis anterior muscle) [16]. Figure 1 presents hypothetic 
mechanism of acupuncture’s effect on immune system.
Considering researchers’ findings concerning the fact 
that acupuncture increases cytotoxic NK cells activity, it is in-
triguing to notice acupuncture’ indirect effect on activity of 
antigen presenting cells (APC), especially on dendritic cells 
(DCs). These cells transform antigens from tumor dead cells 
and, presenting them to lymphocytes T, trigger initiation of 
the adaptive immune response [17]. DCs have also the ability 
to directly, selectively and effectively kill tumor cells through 
apoptosis by the engagement of ligands of TNF receptor fam-
ily with the corresponding cancer cell receptors [18].
NK cells play an additional immunoregulatory function 
as they are capable of stimulating DCs, initiating their matu-
ration in the bone marrow and significantly increasing their 
ability to produce pro-inflammatory cytokines and induce 
immune response mediated by T1 helper cells (Th1) and 
cytotoxic T lymphocytes (Tc) [19].  NK cells and DCs interac-
tions are triggered by receptors and ligands of the TNF fam-
ily receptors [20]. Increased NK cells efficacy in killing trans-
Fig. 1. Hypothetical model explaining how acupuncture stimulates the immune system (based on [11])
Puncture of ST-36 point induces NOS in the keratinocytes, which results in increased concentration of NO. NO transmits signal to the appropriate neural centers 
located in the brain, including the lateral hypothalamic field. This leads to the production of β-endorphin in this area that is followed by increased β-endorphin 
peripheral blood concentration. β-endorphins, binding to opioid NK-cell membrane receptors, activate NK cells and thus stimulate IFN-γ production. IFN-γ influ-
ences other immune system cells that produce IL-2, which is a strong NK cells stimulator.
NOS – nitric oxide synthase; NO – nitrogen oxide; NK – natural killer; IFN-γ – interferon γ; IL-2 – interleukin 2
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formed cells may additionally facilitate formation of antigen 
material derived from decomposing tumour cells, which, in 
turn, induces development of the secondary, adaptive im-
mune response by DCs and T lymphocytes  [11].
There is also suggestion that acupuncture works through 
the regulatory pathway of the Spi-1 proto-oncogene (SPI1). 
SPI1 encodes PU.1 transcription factor that masters the pro-
cess of proliferation and maturation of the hematopoietic 
system cells [21]. To be more specific, it plays a special role 
in stem cells stimulation in the bone marrow and increas-
es the number of mature NK cells [22].  In an experimental 
study carried out on animals, acupuncture has been found 
to induce an increase in the expression of c-Jun gene, which 
is a co-activator of PU.1 [11, 23]  This finding suggests that 
acupuncture might work through the PU.1 pathway to regu-
late NK cells proliferation [23, 24].
Table 1 summarizes possible immunomodulating ef-
fects of acupuncture. Table 2 presents studies exemplify-
ing acupuncture’s role in stimulating the immune system.
The acupuncture’s anticancer effect
In Table 3 research concerning acupuncture’s possi-
ble direct antitumor activity was collected. Most of the 
Table 1. Summary of possible immunomodulating effects of acupuncture
Possible immunomodulating  
effects of acupuncture
Results Ref.
NK cell activation –  direct antitumor activity through both secretory and non-secretory mechanism of 
killing cancer cells
– induction of the secondary adaptive immune response by DCs and T lymphocytes 
[14, 17, 19, 
20]
SPI1 pathway activation –  bone marrow stem cells stimulation
–  proliferation and maturation of the immune system cells
[24]
Increased IL-2 level –  NK cells stimulation
–  expression of  1NKp44 receptor on NK-cell surface 
[25, 26] 
NO synthesis –  NK cells activation
–  induction of NK cells proliferation
[27]
Increased endogenous B-endorphin IFN-γ synthesis [28]
Increased IFN-γ level Mediates NK cell activity:
–  increased expression of TNF superfamily ligands and NK cells receptors
–  stimulate secretion of cytokines through other immune cells
[27, 29, 30]
1NKp44: NK-cell surface receptor, one of the major receptors responsible for triggering NK cell cytotoxic activity [26]
NK cell – natural killer cell; DC – dendritic cell; SPI1 – Spi-1 proto-oncogene; IL – interleukin; NO – nitrogen oxide; IFN-γ  – interferon γ; TNF – tumor necrosis factor
Table 2. Examples of studies concerning acupuncture’s immunomodulating effects
Study type Results Ref.
Animal model Mice with transplanted mammary cancer
–  significantly increased NK cell activity in acupunctured group in comparison to controls (p < 0.01)
–  higher degree of lymphocytic infiltration of tumor (p < 0.05)                                      
[9]
Animal model –  increased NK activity (p < 0.05) and level of IFN-γ (p < 0.05) in acupunctured group
–  no significant difference in NK splenic population
[28]
Animal model –  significantly enhanced NK cell splenic cytotoxity  (p < 0.001)
–  increased level of  IFN-γ and IL-2 in comparison to non-acupunctured group (p < 0.01)
–  positive correlation between NK cells cytotoxity and the level of each cytokine was observed (p < 0.01)
[29]
Case series 60 patients with metastatic colorectal cancer
–  significantly increased level of NK cells in peripheral blood after acupuncture (patients with metastatic 
colorectal cancer)
[10]
Case series 17 healthy volunteers
–  increase in IFN-γ serum level and markers of peripheral NK cells activity: CD16+ (p < 0.05) and CD56+ cells  
(p < 0.01)
[30]
Lack of data 45 patients with malignant tumors (20 controls)
–  levels of IL-2 and NK cell activity significantly increased in study group (p < 0.01)
[31]
RCT (phase II) 51 patients with malignant neoplasm, 48 healthy controls
–  significant increase in the level of CDT3+, CDT4+, CDT8+ cells in acupunctured group
[32]
Lack of data 40 patients with malignant tumors (20 controls), acupunctured group exhibited:
–  increased level of T lymphocyte subsets CD3+, CD4+, CD4+/CD8+ (p < 0.01)
–  increase in β-endorphin serum concentration (p < 0.01)
–  decreased level of solulable interleukin-2 receptor (p < 0.01)
[33]
NK – natural killer; IFN-γ – interferon γ; IL-2 – interleukin 2; RCT – randomized controlled trial; CD – cluster of differentiation
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referred studies were conducted on animal models. The 
majority of the authors suggest that this method can ef-
fectively diminish tumor volume [9, 34, 37–39]. Also, some 
papers point to its potential application as additional 
therapy to the classic anticancer treatment [35, 40]. One 
trial presents some of the molecular effects of acupoint 
stimulation, which were suggested to inhibit cancer cell 
activity [36]. It is essential to notice that results of one 
of the analyzed studies exhibited two opposite effects of 
acupoint stimulation, depending on the day of acupunc-
ture initiation following transplantation of cancer cell into 
animal organism [39]. That, despite being the only report 
to be found to present tumor activity stimulation, can im-
ply that the mechanism of acupuncture is still not being 
properly explicated, thus cannot be trusted enough to be 
introduced into clinical setting. 
Reliability of the studies
The major problem of the research concerning antitu-
mor activity is that it is scant. Although the results of the 
majority of presented studies are promising, some of them 
lack such elements as detailed methodology description, 
sufficient number of subjects, group characteristics or sta-
tistical significance of results, which makes it difficult to 
assess and compare. Moreover, the alarming pro-cancer 
effect revealed in one of the referred studies indicates that 
due to the inconsiderable amount of data, further well-de-
signed research is required. 
Summary
Since recent studies have brought about a significant 
progress in immunotherapy of malignant tumours, the 
strategy of implementing acupuncture into clinical setting, 
based on its immunostimulating potential, seems prom-
ising [42]. However, as of today the potential combined 
use of this therapy with tumour immunotherapy in order 
to increase the efficacy of anticancer treatment can be 
seen only as an experimental approach. Both the quantity 
and the quality of data that is available for now require 
improvement and further scientific attempt in this field is 
needed. 
The authors would like to thank Ms Joanna Gołąb for 
editing the article. 
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Table 3. Studies concerning acupuncture as anticancer treatment.
Study type Results Ref.
Case series patients with superficial tumors underwent electroacupuncture: 
–  123 were CR
–  129 were PR
–  36 with their tumor shrinked by 1/4 
–  32 – no change in tumor size was observed 
The ORR (CR + PR) was 78.7%
[34]
Case series 106 patients with liver cancer
–  the ORR was the highest (73.7%) in the group where both electroacupuncture and liver artery intubation 
chemotherapy were performed
–  the other two groups of either electroacupuncture or liver artery intubation chemotherapy presented 
with ORR of 55.6% and 28.1% respectively
[35]
Case series Omura’s ST36 point stimulation:
–  decrease in cancer cell telomere, integrin α5β1 and oncogen C-fos Ab2 expression 
[36]
Case report 52-year-old woman with DCIS
–  regression of DCIS after treatment with acupuncture
[37]
Animal model Mice with transplanted mammary cancer
–  acupunctured group exhibited less tumor volume (p < 0.01)
–  higher lymphocytic infiltration degree of tumor (p < 0.05)                                      
[9]
Animal model Liver cancer, gastric cancer and hypodermic tumor rat models were obtained by implantation of replicated 
Walker-256 cell strain.
–  the gross tumor volume in electroacupunctured group was significantly smaller than in control group  
(p < 0.05)
[38]
Animal model Mice with implanted osteosarcoma – stimulation of ST36 acupoint:
–  twice weekly beginning at postimplantation day 3: reduction in tumor growth, tumor lymphatics, 
vasculature and innervation; marked reduction in pulmonary metastasis
–  twice weekly starting at postimplantation day 7: significant increase in tumor growth
[39]
Animal model Mice with inoculated Lewis lung carcinoma
–  group of acupuncture combined with paclitaxel presented significantly lower tumor mass than in both 




–  enhancement of immediate tumor response [41]
CR – complete remission; PR – partial remission; ORR – overall response rate; DCIS – ductal carcinoma in situ
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